meta_pixel
Tapesearch Logo
Log in
Skincare Anarchy

Daniel Isaacs, Research Director for Medik8 Skincare

Skincare Anarchy

Ekta et al.

Fragrance, Fashion, Entertainment News, Fashion & Beauty, Education, Entrepreneurship, Skincare, Skin, News, Makeup, Style, Dermatology, Self-improvement, Beauty, Arts

4.22K Ratings

🗓️ 14 February 2022

⏱️ 39 minutes

🧾️ Download transcript

Summary

Daniel Isaacs is the Director of Research at Medik8 - one of the UK’s fastest growing skincare companies loved by industry professionals, beauty editors and skincare enthusiasts. Daniel has always been fascinated by science and studied chemistry at the University of Leeds. He later joined his brother Elliot’s company, Medik8, as a product formulator in the research and development department. He now heads up the department and leads a large team of biochemists, formulators and packaging specialists, who are constantly driving innovation in the skin care arena. During his career, Daniel has developed over 80 unique formulations. He is an industry expert in sunscreens and pigmentation and is the inventor of two patents in skin brightening. He is also the innovator behind Medik8’s renowned H.E.O. smart hydration technologies. His knowledge and expertise is regularly called upon by the world’s media, with him being featured in Vogue, Forbes, The Telegraph, The Times and more.--- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/supportSupport the show

Follow The Show On All Socials Using The Tag @skincareanarchy

Transcript

Click on a timestamp to play from that location

0:00.0

Diablo 4 has arrived as the forces of hell gather only you can stand in their way.

0:07.0

Journey across the expanse of open world of sanctuary. Choose from five powerful classes

0:12.8

then progress them to fit your playstyle. Adventure with your friends and up to four

0:16.8

player co-op with cross playing cross progression on all platforms. Welcome to hell.

0:22.5

Diablo 4 available now rated M for mature. Tap the banner or visit this episode's

0:27.5

page to learn more.

0:30.0

Hi guys. Welcome back to skincare andarchy. This is Ecta as always. I want to introduce

0:53.8

you guys to an amazing guest today and this brand is something I've always really kind

0:59.4

of looked at as really in at the forefront of science from super excited to be interviewing

1:04.8

them today. But without further ado, I want to introduce you guys to the director of

1:08.6

research for medic 8. And I'm sure all of you have heard of the brand Daniel Isaacs.

1:14.5

So welcome to the show Dan. I'm so excited to hear.

1:17.1

Thanks actually. Yeah, it's an absolute pleasure to be here looking forward to it.

1:21.2

Yeah, no, I'm excited to finally learn about this brand because I've seen Medicaid everywhere

1:27.8

right. So it's it's just like something I've never known about the real science that went

1:32.8

behind it. But first to get started, I want to ask you about your your career and how

1:37.5

you ended up with the company and how all of this came to be.

1:40.9

Good. I mean lots of good questions in there. So I got into the world of skincare through

1:49.4

a more of a pure chemistry route. That's what I studied at university and straight after

1:55.6

university, there was an opportunity that came up with my brother who, as you said, founded

2:01.0

originally founded Medicaid. And it was a it was a sort of a baptism of fire as it were

2:10.7

because Elliot had this very bold vision from from the very early days of Medicaid where

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Ekta et al., and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Ekta et al. and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.